ALLO icon

Allogene Therapeutics
ALLO

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$11
370% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Canaccord Genuity
Canaccord Genuity
John Newman
0% 1-yr ALLO win rate
13 Mar ‘26 1 month ago
Piper Sandler
Piper Sandler
Biren Amin
50% 1-yr ALLO win rate
13 Mar ‘26 1 month ago